Skip to Content

M L 4 (Levothyroxine Sodium 25 mcg (0.025 mg))

Pill with imprint M L 4 is Orange, Capsule-shape and has been identified as Levothyroxine Sodium 25 mcg (0.025 mg). It is supplied by Mylan Pharmaceuticals Inc..

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for M L 4

Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Front
Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Back
Levothyroxine sodium 25 mcg (0.025 mg) M L 4
Levothyroxine sodium 25 mcg (0.025 mg) M L 4

Levothyroxine Sodium

Imprint
M L 4
Strength
25 mcg (0.025 mg)
Color
Orange
Size
9.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Thyroid drugs
Pregnancy Category
A - Studies show no risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
butylated hydroxyanisole, silicon dioxide, magnesium stearate, mannitol, microcrystalline cellulose, sodium lauryl sulfate, sucrose, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-1800 Mylan Pharmaceuticals Inc.
51079-0444 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M L 4"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.